221 related articles for article (PubMed ID: 23321360)
1. Quality of generic ophthalmic drugs.
Novack GD
Ocul Surf; 2013 Jan; 11(1):54-6. PubMed ID: 23321360
[No Abstract] [Full Text] [Related]
2. Multinational medicines--ensuring drug quality in an era of global manufacturing.
Okie S
N Engl J Med; 2009 Aug; 361(8):737-40. PubMed ID: 19692686
[No Abstract] [Full Text] [Related]
3. When Is a Medicine Good Enough?: Science, Similarity, and the History of Generic Drugs.
Greene JA
Clin Pharmacol Ther; 2019 Feb; 105(2):290-291. PubMed ID: 30703267
[No Abstract] [Full Text] [Related]
4. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.
Palylyk-Colwell E; Jamali F; Dryden W; Friesen E; Koven S; Mohamed I; Osmond B; Alessi-Severini S; Sheldon L; Sheldon R; Tam Y; Tsuyuki R; Zhanel G
J Pharm Pharm Sci; 1998; 1(1):2-7. PubMed ID: 10942966
[No Abstract] [Full Text] [Related]
5. Regulatory status of medicinal products for human beings in the European Union. The role of generic products.
Minghetti P
Pharmacol Res; 1996; 34(1-2):3-7. PubMed ID: 8981548
[TBL] [Abstract][Full Text] [Related]
6. [Generic prescription should be evaluated as new way of prescription in Denmark].
Hellebek A; Søndergaaard J; Thirstrup S; Sales Y
Ugeskr Laeger; 2012 Aug; 174(35):1974. PubMed ID: 22929572
[No Abstract] [Full Text] [Related]
7. Lawsuits anticipated on generic biologicals front.
Fox JL
Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
[No Abstract] [Full Text] [Related]
8. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
Marsh DA; Hoar ME
Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
[TBL] [Abstract][Full Text] [Related]
9. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-third report.
World Health Organ Tech Rep Ser; 1993; 834():1-30. PubMed ID: 8362524
[No Abstract] [Full Text] [Related]
10. Consideration of international generic distribution policies on patient outcomes in the United States and Germany.
Saverno K; Gothe H; Schuessel K; Biskupiak J; Schulz M; Siebert U; Brixner D
Pharmazie; 2014 Mar; 69(3):238-40. PubMed ID: 24716417
[TBL] [Abstract][Full Text] [Related]
11. Current Regulation for Bioequivalence Evaluations of Generic Ophthalmic Dosage Forms in Japan.
Myoenzono A; Kuribayashi R; Yamaguchi T; Ogawa T; Takagi K
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):697-702. PubMed ID: 32930951
[TBL] [Abstract][Full Text] [Related]
12. The case for standardizing the appearance of bioequivalent medications.
Engelberg AB
J Manag Care Pharm; 2011 May; 17(4):321-3. PubMed ID: 21534643
[No Abstract] [Full Text] [Related]
13. Clinical Endpoint Bioequivalence Studies Are Needed: A Perspective From Brand Drugs.
Krishna R; Kesisoglou F
Clin Pharmacol Ther; 2019 Feb; 105(2):298-300. PubMed ID: 30456848
[No Abstract] [Full Text] [Related]
14. Are generic and brand name drugs different in terms of quality?
Johns Hopkins Med Lett Health After 50; 2000 Feb; 11(12):8. PubMed ID: 10732507
[No Abstract] [Full Text] [Related]
15. [Generics and brands in chemotherapy].
Grigor'ev VIu
Antibiot Khimioter; 2006; 51(8):38-47. PubMed ID: 18030783
[No Abstract] [Full Text] [Related]
16. The integrity of generic drugs.
Fisher DW
Hosp Pract (Off Ed); 1989 Sep; 24(9):9. PubMed ID: 2504753
[No Abstract] [Full Text] [Related]
17. [Generics: authorization to market and quality guarantees].
De Muylder JA
Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
[TBL] [Abstract][Full Text] [Related]
18. Generic and alternative brand-name pharmaceutical equivalents: select with caution.
Hendeles L; Hochhaus G; Kazerounian S
Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793
[No Abstract] [Full Text] [Related]
19. Generic vs. brand name drugs--defining and enforcing standards.
Lasagna LC
Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827
[No Abstract] [Full Text] [Related]
20. Low molecular weight heparins differ substantially: impact on developing biosimilar drugs.
Walenga JM; Jackson CM; Kessler CM
Semin Thromb Hemost; 2011 Apr; 37(3):322-7. PubMed ID: 21455866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
